Scarica l'app Stockscreener
0.67
8.21%
-0.0599
Pre-mercato:
.67
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché HSDT Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.7299
Aprire:
$0.719
Volume 24 ore:
106.15K
Relative Volume:
0.05
Capitalizzazione di mercato:
$2.50M
Reddito:
$502.00K
Utile/perdita netta:
$-8.86M
Rapporto P/E:
-0.1182
EPS:
-5.67
Flusso di cassa netto:
$-10.71M
1 W Prestazione:
-4.61%
1M Prestazione:
+19.60%
6M Prestazione:
-27.18%
1 anno Prestazione:
-91.38%
Intervallo 1D:
$0.62
$0.729
Intervallo di 1 settimana:
$0.62
$0.757
Portata 52W:
$0.373
$9.50
Helius Medical Technologies Inc Stock (HSDT) Company Profile
Nome
Helius Medical Technologies Inc
Settore
Industria
Telefono
215-944-6100
Indirizzo
642 NEWTOWN YARDLEY ROAD, NEWTOWN, PA
Confronta HSDT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HSDT
Helius Medical Technologies Inc
|
0.67 | 2.50M | 502.00K | -8.86M | -10.71M | -5.67 |
|
ABT
Abbott Laboratories
|
114.25 | 198.16B | 41.22B | 5.77B | 6.49B | 3.29 |
|
BSX
Boston Scientific Corp
|
95.95 | 141.41B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
364.10 | 138.80B | 21.97B | 3.59B | 3.21B | 9.33 |
|
MDT
Medtronic Plc
|
82.68 | 106.02B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
74.15 | 43.73B | 6.60B | 4.16B | 490.10M | 6.93 |
Helius Medical Technologies Inc Stock (HSDT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-03-24 | Iniziato | Noble Capital Markets | Outperform |
Helius Medical Technologies Inc Borsa (HSDT) Ultime notizie
Helius Medical Achieves Key Milestone with First PoNS System Sale to VA - MSN
Thinking about buying stock in Scilex Holding, iCoreConnect, Genius Group, Helius Medical Technologies, or TradeUP Acquisition? - Marketscreener.com
Helius Medical Technologies, Inc. Announces First PoNS System Sale to VA Healthcare SystemOn December 23, 2024, Helius Medical Technologies, Inc. (NASDAQ:HSDT) disclosed its successful sale of the first Portable Neuromodulation Stimulator (PoNS) - Defense World
Helius Announces First Portable Neuromodulation Stimulator (PoNS®) System Sale to the Veterans Affairs (VA) Healthcare System - The Manila Times
Helius Announces First Portable Neuromodulation Stimulator - GlobeNewswire
Helius Medical Technologies, Inc. (NASDAQ:HSDT) Sees Large Drop in Short Interest - Defense World
Helius Medical Technologies Lists on the Canadian Securities ExchangeVideo News Alert on Investmentpitch.com - Marketscreener.com
Helius Medical Technologies Seeks Fair Market Access for PoNS Device Amid CMS Pricing Challenges - MSN
Helius Medical Technologies Reports Q3 2024 Earnings - MSN
Newtown-based Helius Medical Technologies Explores ‘Strategic Alternatives’ to Boost Stockholder Value - BUCKSCO.Today
Helius Medical Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Helius Medical Technologies Considers Strategic Alternatives Amid Financial Challenges - MSN
Neuronetics to Showcase Neurohealth Innovations at Piper Sandler Healthcare Conference! - MSN
Modular Medical announces proposed public offering - MSN
Helius to explore 'strategic alternatives' with revenue from flagship product stunted by pricing issues - The Business Journals
Helius Medical Explores Strategic Alternatives - Marketscreener.com
Regenxbio down 13% ahead of data readout for muscular dystrophy asset - MSN
Grandshores Technology Expects Increased Loss Amid Forex Challenges - MSN
Helius Medical Technologies Initiates Strategic Alternatives to Maximize Stockholder ValueNEWTOWN, Pa., Nov. 18, 2024 / Helius Medical Technologies, Inc. (NASDAQ:HSDT) announced on November 18, 2024, the initiation of a process to explore strategic - Defense World
Helius seeks fair market access for MS treatment device By Investing.com - Investing.com Australia
Helius Medical Technologies, Inc. Announces Exploration of Strategic Alternatives - GlobeNewswire
Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for Its Portable Neuromodulation Stimulator Device - Marketscreener.com
Helius Medical Technologies Faces Nasdaq Delisting Risk Due to Stock Price Non-Compliance - TipRanks
Helix Biopharma announces CFO resignation - MSN
Helius Medical Technologies Challenges CMS Over PoNS Payment Rates - MSN
Helius Medical Technologies to Shine at ThinkEquity Conference in NYC! - MSN
Alignment Healthcare to Announce Third Quarter 2024 Financial Results and Host Conference Call Tuesday, Oct. 29, 2024 - The Manila Times
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference - GlobeNewswire
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference - GlobeNewswire Inc.
Helius opposes Medicare, Medicaid coverage amounts for PoNS device - Multiple Sclerosis News Today
Adversity is less terrifying than hope: Helius Medical Technologies Inc (HSDT) - SETE News
Maxim cuts Helius Medical shares to hold on CMS reimbursement woes - Investing.com India
HSDT’s Market Whiplash: -95.35% YTD Decline, -53.82% Plunge in 30 Days - The InvestChronicle
Maxim cuts Helius Medical shares to hold on CMS reimbursement woes By Investing.com - Investing.com South Africa
Financial Health Check: Examining Helius Medical Technologies Inc (HSDT)’s Key Ratios - The Dwinnex
Helius to challenge CMS’ reimbursement determination for PoNS - Medical Buyer
Helius challenges CMS over PoNS device reimbursement rate - Investing.com India
Helius challenges CMS over PoNS device reimbursement rate By Investing.com - Investing.com South Africa
Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece - The Manila Times
Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from - The Bakersfield Californian
Helius Medical Technologies, Inc. Announces Reimbursement - GlobeNewswire
Helius Medical Technologies Inc Azioni (HSDT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.54%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):